在包括波拉图祖马布维多丁在内的联合治疗后,中枢神经系统复发在患有扩散大B细胞淋巴瘤的患者中
Yoshikazu Hori1, Hiroki Hosoi1, Toshiki Mushino1
1Department of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan.
Leukemia research reports
|June 28, 2024
概括
在扩散性大B细胞淋巴瘤 (DLBCL) 中预防中枢神经系统 (CNS) 复发仍然是困难的. 两个案例表明,含波拉图祖马布维多丁 (PV) 的疗法可能无法预防中枢神经系统复发,因此需要新的策略.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 临床研究 临床研究
背景情况:
- 中枢神经系统 (CNS) 复发是治疗扩散型大B细胞淋巴瘤 (DLBCL) 的重大挑战.
- 含波拉图祖马布维多丁 (PV) 治疗方案在预防中枢神经系统复发方面的疗效尚未先前研究.
更多相关视频
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
3.3K
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
485
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Immunotherapy
510
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
510
